<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34853527</PMID><DateRevised><Year>2021</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7031</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Journal of inflammation research</Title><ISOAbbreviation>J Inflamm Res</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases.</ArticleTitle><Pagination><StartPage>6191</StartPage><EndPage>6221</EndPage><MedlinePgn>6191-6221</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/JIR.S332705</ELocationID><Abstract><AbstractText>Coronavirus disease-2019 (COVID-19) is asymptomatic in most cases, but it is impartible and fatal in fragile and elderly people. Heretofore, more than four million people succumbed to COVID-19, while it spreads to every part of the globe. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) induces various dysfunctions in many vital organs including the thyroid by utilizing ACE2 as a receptor for cellular entry. Emerging reports clearly show the involvement of SARS-CoV-2 in diverse thyroid disorders. Thus, this review article aims to review comprehensively all the recent developments in SARS-CoV-2-induced pathogenesis of thyroid diseases. The review briefly summarizes the recent key findings on the mechanism of SARS-CoV-2 infection, the role of ACE2 receptor in viral entry, SARS-CoV-2-activated molecular signaling in host cells, ACE2 expression in the thyroid, cytokine storm, and its vital role in thyroid dysfunction and long-COVID in relation to thyroid and autoimmunity. Further, it extensively discusses rapidly evolving knowledge on the potential part of SARS-CoV-2 in emerging various thyroid dysfunctions during and post-COVID-19 conditions which include subacute thyroiditis, Graves' diseases, Hashimoto's thyroiditis, thyrotoxicosis, and other recent advances in further discerning the implications of this virus within thyroid dysfunction. Unraveling the pathophysiology of SARS-CoV-2-triggered thyroid dysfunctions may aid pertinent therapeutic options and management of these patients in both during and post-COVID-19 scenarios.</AbstractText><CopyrightInformation>&#xa9; 2021 Murugan and Alzahrani.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murugan</LastName><ForeName>Avaniyapuram Kannan</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0002-3096-6100</Identifier><AffiliationInfo><Affiliation>Division of Molecular Endocrinology, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzahrani</LastName><ForeName>Ali S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Division of Molecular Endocrinology, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>J Inflamm Res</MedlineTA><NlmUniqueID>101512684</NlmUniqueID><ISSNLinking>1178-7031</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Graves&#x2019; disease</Keyword><Keyword MajorTopicYN="N">Hashimoto&#x2019;s thyroiditis</Keyword><Keyword MajorTopicYN="N">IL6</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">hyperthyroidism</Keyword><Keyword MajorTopicYN="N">hypothyroidism</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">p38/MAPK</Keyword><Keyword MajorTopicYN="N">subacute thyroiditis</Keyword><Keyword MajorTopicYN="N">thyroid</Keyword><Keyword MajorTopicYN="N">thyroid cancer</Keyword><Keyword MajorTopicYN="N">thyrotoxicosis</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest for this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34853527</ArticleId><ArticleId IdType="pmc">PMC8628126</ArticleId><ArticleId IdType="doi">10.2147/JIR.S332705</ArticleId><ArticleId IdType="pii">332705</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fan E, Beitler JR, Brochard L, et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med. 2020;8(8):816&#x2013;821. doi:10.1016/S2213-2600(20)30304-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30304-0</ArticleId><ArticleId IdType="pmc">PMC7338016</ArticleId><ArticleId IdType="pubmed">32645311</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 data portal, Center for Systems Science and Engineering, The Johns Hopkins University, Baltimore MD USA. Available from:
https://coronavirus.jhu.edu/. Accessed October
01, 2021.</Citation></Reference><Reference><Citation>Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45. doi:10.1186/s40249-020-00662-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayan SS, Lorenz K, Ukkat J, Hoang-Vu C, Trojanowicz B. Angiotensin converting enzymes ACE and ACE2 in thyroid cancer progression. Neoplasma. 2020;67(2):402&#x2013;409. doi:10.4149/neo_2019_190506N405</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/neo_2019_190506N405</ArticleId><ArticleId IdType="pubmed">31847529</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260&#x2013;1263. doi:10.1126/science.abb2507</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875&#x2013;879. doi:10.1038/nm1267</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1267</ArticleId><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipnis SR, Hooper NM, Hyde R, Karran E, Christie, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000;275(43):33238&#x2013;33243. doi:10.1074/jbc.M002615200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M002615200</ArticleId><ArticleId IdType="pubmed">10924499</ArticleId></ArticleIdList></Reference><Reference><Citation>Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87(5):E1&#x2013;9. doi:10.1161/01.res.87.5.e1</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.res.87.5.e1</ArticleId><ArticleId IdType="pubmed">10969042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Cooper ME, Haagmans BL, et al. The emerging role of ACE2 in physiology and disease. J Pathol. 2007;212(1):1&#x2013;11. doi:10.1002/path.2162</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2162</ArticleId><ArticleId IdType="pmc">PMC7167724</ArticleId><ArticleId IdType="pubmed">17464936</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers C, Hales P, Kaushik V, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. 2002;277(17):14838&#x2013;14843. doi:10.1074/jbc.M200581200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M200581200</ArticleId><ArticleId IdType="pubmed">11815627</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181(2):281&#x2013;292.e6. doi:10.1016/j.cell.2020.02.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi M, Shi X, Huo X, Wu X, Zhang P, Wang G. Dexmedetomidine promotes breast cancer cell migration through Rab11-mediated secretion of exosomal TMPRSS2. Ann Transl Med. 2020;8(8):531. doi:10.21037/atm.2020.04.28</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2020.04.28</ArticleId><ArticleId IdType="pmc">PMC7214880</ArticleId><ArticleId IdType="pubmed">32411754</ArticleId></ArticleIdList></Reference><Reference><Citation>Glowacka I, Bertram S, Muller MA, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011;85(9):4122&#x2013;4134. doi:10.1128/JVI.02232-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02232-10</ArticleId><ArticleId IdType="pmc">PMC3126222</ArticleId><ArticleId IdType="pubmed">21325420</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271&#x2013;280.e8. doi:10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, P&#xf6;hlmann S. A multibasic cleavage site in the spike protein of sars-cov-2 is essential for infection of human lung cells. Mol Cell. 2020;78(4):779&#x2013;784.e5. doi:10.1016/j.molcel.2020.04.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.04.022</ArticleId><ArticleId IdType="pmc">PMC7194065</ArticleId><ArticleId IdType="pubmed">32362314</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly JL, Simonetti B, Klein K, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370(6518):861&#x2013;865. doi:10.1126/science.abd3072</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3072</ArticleId><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370(6518):856&#x2013;860. doi:10.1126/science.abd2985</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450&#x2013;454. doi:10.1038/nature02145</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId><ArticleId IdType="pmc">PMC7095016</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain M, Jabeen N, Raza F, et al. Structural Variations in Human ACE2 may Influence its Binding with SARS-CoV-2 Spike Protein. J Med Virol. 2020;92(9):1580&#x2013;1586. doi:10.1002/jmv.25832</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25832</ArticleId><ArticleId IdType="pmc">PMC7228372</ArticleId><ArticleId IdType="pubmed">32249956</ArticleId></ArticleIdList></Reference><Reference><Citation>Epelman S, Tang WHW, Chen SY, Van Lente F, Francis GS, Sen S. Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure: insights Into the Endogenous Counter-Regulatory Pathway of the Renin-Angiotensin-Aldosterone System. J Am Coll Cardiol. 2008;52(9):750&#x2013;754. doi:10.1016/j.jacc.2008.02.088</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.02.088</ArticleId><ArticleId IdType="pmc">PMC2856943</ArticleId><ArticleId IdType="pubmed">18718423</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou M, Memon D, Meyer B, et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020;182(3):685&#x2013;712.e19. doi:10.1016/j.cell.2020.06.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.034</ArticleId><ArticleId IdType="pmc">PMC7321036</ArticleId><ArticleId IdType="pubmed">32645325</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann K, Bojkova D, Tascher G, Ciesek S, M&#xfc;nch C, Cinatl J. Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication. Mol Cell. 2020;80(1):164&#x2013;174.e4. doi:10.1016/j.molcel.2020.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.08.006</ArticleId><ArticleId IdType="pmc">PMC7418786</ArticleId><ArticleId IdType="pubmed">32877642</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojkova D, Klann K, Koch B, et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020;583(7816):469&#x2013;472. doi:10.1038/s41586-020-2332-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2332-7</ArticleId><ArticleId IdType="pubmed">32408336</ArticleId></ArticleIdList></Reference><Reference><Citation>Facchiano A, Facchiano F, Facchiano A. An investigation into the molecular basis of cancer comorbidities in coronavirus infection. FEBS Open Bio. 2020;10(11):2363&#x2013;2374. doi:10.1002/2211-5463.12984</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.12984</ArticleId><ArticleId IdType="pmc">PMC7537529</ArticleId><ArticleId IdType="pubmed">32970391</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovanella L, Ruggeri RM, Ov&#x10d;ari&#x10d;ek PP, Campenni A, Treglia G, Deandreis D. Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review. Clin Transl Imaging. 2021;1&#x2013;8. doi:10.1007/s40336-021-00419-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40336-021-00419-y</ArticleId><ArticleId IdType="pmc">PMC7950424</ArticleId><ArticleId IdType="pubmed">33728279</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Lee CH, Chow WS, et al. Thyroid Dysfunction in Relation to Immune Profile, Disease Status and Outcome in 191 Patients with COVID-19. J Clin Endocrinol Metab. 2021;106(2):e926&#x2013;e935. doi:10.1210/clinem/dgaa813</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa813</ArticleId><ArticleId IdType="pmc">PMC7665541</ArticleId><ArticleId IdType="pubmed">33141191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Lee CH, Chow WS, et al. Insights from a Prospective Follow-up of Thyroid Function and Autoimmunity among COVID-19 Survivors. Endocrinol Metab. 2021;36(3):582&#x2013;589. doi:10.3803/EnM.2021.983</Citation><ArticleIdList><ArticleId IdType="doi">10.3803/EnM.2021.983</ArticleId><ArticleId IdType="pmc">PMC8258341</ArticleId><ArticleId IdType="pubmed">34107601</ArticleId></ArticleIdList></Reference><Reference><Citation>Poma AM, Bonuccelli D, Giannini R, et al. COVID-19 autopsy cases: detection of virus in endocrine tissues. J Endocrinol Invest. 2021:1&#x2013;6. doi:10.1007/s40618-021-01628-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01628-y</ArticleId><ArticleId IdType="pmc">PMC8243303</ArticleId><ArticleId IdType="pubmed">34191258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara JL. Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol. 1993;5(5):794&#x2013;799. doi:10.1016/0952-7915(93)90139-j</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0952-7915(93)90139-j</ArticleId><ArticleId IdType="pubmed">8240742</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473&#x2013;474. doi:10.1126/science.abb8925</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8925</ArticleId><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420&#x2013;422. doi:10.1016/S2213-2600(20)30076-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383(25):2451&#x2013;2460. doi:10.1056/NEJMcp2009575</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009575</ArticleId><ArticleId IdType="pubmed">32412710</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718&#x2013;724. doi:10.1126/science.abc6027</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25&#x2013;32. doi:10.1016/j.cytogfr.2020.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.05.003</ArticleId><ArticleId IdType="pmc">PMC7211650</ArticleId><ArticleId IdType="pubmed">32446778</ArticleId></ArticleIdList></Reference><Reference><Citation>Croce L, Gangemi D, Ancona G, et al. The cytokine storm and thyroid hormone changes in COVID-19. J Endocrinol Invest. 2021;44(5):891&#x2013;904. doi:10.1007/s40618-021-01506-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01506-7</ArticleId><ArticleId IdType="pmc">PMC7871522</ArticleId><ArticleId IdType="pubmed">33559848</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355&#x2013;362. doi:10.1038/s41577-020-0331-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 Cytokine Storm; What We Know So Far. Front Immunol. 2020;11:1446. doi:10.3389/fimmu.2020.01446</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01446</ArticleId><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>Hue S, Beldi-Ferchiou A, Bendib I, et al. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020;202(11):1509&#x2013;1519. doi:10.1164/rccm.202005-1885OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202005-1885OC</ArticleId><ArticleId IdType="pmc">PMC7706149</ArticleId><ArticleId IdType="pubmed">32866033</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S, Meschiari M, Gibellini L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11(1):3434. doi:10.1038/s41467-020-17292-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17292-4</ArticleId><ArticleId IdType="pmc">PMC7338513</ArticleId><ArticleId IdType="pubmed">32632085</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine Storm in COVID-19: the Current Evidence and Treatment Strategies. Front Immunol. 2020;11:1708. doi:10.3389/fimmu.2020.01708</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01708</ArticleId><ArticleId IdType="pmc">PMC7365923</ArticleId><ArticleId IdType="pubmed">32754163</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri RM, Giuffrida G, Campenn&#xec; A. Autoimmune endocrine diseases. Minerva Endocrinol. 2018;43(3):305&#x2013;322. doi:10.23736/S0391-1977.17.02757-2</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0391-1977.17.02757-2</ArticleId><ArticleId IdType="pubmed">28990742</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri RM, Campenn&#xec; A, Deandreis D, et al. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev Clin Immunol. 2021;17(7):737&#x2013;759. doi:10.1080/1744666X.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2021</ArticleId><ArticleId IdType="pmc">PMC8182818</ArticleId><ArticleId IdType="pubmed">34015983</ArticleId></ArticleIdList></Reference><Reference><Citation>Minciullo PL, Ruggeri RM, Vita G, Benvenga S, Gangemi S. Development of Hashimoto&#x2019;s thyroiditis after subacute thyroiditis: an unusual patient. Thyroid. 2009;19(1):73&#x2013;74. doi:10.1089/thy.2008.0234</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2008.0234</ArticleId><ArticleId IdType="pubmed">19072672</ArticleId></ArticleIdList></Reference><Reference><Citation>Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodr&#xed;guez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62&#x2013;75. doi:10.1016/j.cytogfr.2020.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7265853</ArticleId><ArticleId IdType="pubmed">32513566</ArticleId></ArticleIdList></Reference><Reference><Citation>Morshed SA, Latif R, Davies TF. Delineating the autoimmune mechanisms in Graves&#x2019; disease. Immunol Res. 2012;54(1&#x2013;3):191&#x2013;203. doi:10.1007/s12026-012-8312-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-012-8312-8</ArticleId><ArticleId IdType="pmc">PMC4504182</ArticleId><ArticleId IdType="pubmed">22434518</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanba T, Watanabe M, Inoue N, Iwatani Y. Increases of the Th1/Th2 cell ratio in severe Hashimoto&#x2019;s disease and in the proportion of Th17 cells in intractable Graves&#x2019; disease. Thyroid. 2009;19(5):495&#x2013;501. doi:10.1089/thy.2008.0423</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2008.0423</ArticleId><ArticleId IdType="pubmed">19415997</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Wang H, Su Z, et al. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto&#x2019;s thyroiditis. Scand J Immunol. 2010;72(3):250&#x2013;255. doi:10.1111/j.1365-3083.2010.02425.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.2010.02425.x</ArticleId><ArticleId IdType="pubmed">20696023</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Vega N, Alfonso-P&#xe9;rez M, Benedicto I, S&#xe1;nchez-Madrid F, Gonz&#xe1;lez-Amaro R, Marazuela M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto&#x2019;s thyroiditis. J Clin Endocrinol Metab. 2010;95(2):953&#x2013;962. doi:10.1210/jc.2009-1719</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2009-1719</ArticleId><ArticleId IdType="pubmed">20016049</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri RM, Saitta S, Cristani M, et al. Serum interleukin-23 (IL-23) is increased in Hashimoto&#x2019;s thyroiditis. Endocr J. 2014;61(4):359&#x2013;363. doi:10.1507/endocrj.ej13-0484</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.ej13-0484</ArticleId><ArticleId IdType="pubmed">24476945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri RM, Minciullo P, Saitta S, et al. Serum interleukin-22 (IL-22) is increased in the early stage of Hashimoto&#x2019;s thyroiditis compared to non-autoimmune thyroid disease and healthy controls. Hormones. 2014;13(3):338&#x2013;344. doi:10.14310/horm.2002.1483</Citation><ArticleIdList><ArticleId IdType="doi">10.14310/horm.2002.1483</ArticleId><ArticleId IdType="pubmed">25079457</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitales-Noyola M, Ramos-Levi AM, Mart&#xed;nez-Hern&#xe1;ndez R, et al. Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders. Endocrine. 2017;57(3):409&#x2013;417. doi:10.1007/s12020-017-1361-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-017-1361-y</ArticleId><ArticleId IdType="pubmed">28669056</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristensen B, Heged&#xfc;s L, Madsen HO, Smith TJ, Nielsen CH. Altered balance between self-reactive T helper (Th)17 cells and Th10 cells and between full-length forkhead box protein 3 (FoxP3) and FoxP3 splice variants in Hashimoto&#x2019;s thyroiditis. Clin Exp Immunol. 2015;180(1):58&#x2013;69. doi:10.1111/cei.12557</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12557</ArticleId><ArticleId IdType="pmc">PMC4367094</ArticleId><ArticleId IdType="pubmed">25412700</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Wang B, Mu K, Zhang JA. The pathogenesis of thyroid autoimmune diseases: new T lymphocytes&#x2014;cytokines circuits beyond the Th1&#x2212;Th2 paradigm. J Cell Physiol. 2019;234(3):2204&#x2013;2216. doi:10.1002/jcp.27180</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27180</ArticleId><ArticleId IdType="pubmed">30246383</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol. 2007;148(1):32&#x2013;46. doi:10.1111/j.1365-2249.2007.03356.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2007.03356.x</ArticleId><ArticleId IdType="pmc">PMC1868863</ArticleId><ArticleId IdType="pubmed">17328715</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovanella L, Ruggeri RM, Petranovi&#x107; Ov&#x10d;ari&#x10d;ek P, Campenni A, Treglia G, Deandreis D. SARS-CoV-2-related thyroid disorders: a synopsis for nuclear medicine thyroidologists. Eur J Nucl Med Mol Imaging. 2021;48(6):1719&#x2013;1723. doi:10.1007/s00259-021-05316-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05316-0</ArticleId><ArticleId IdType="pubmed">33765218</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi:10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi:10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta EM, Spallone A, Rodriguez-Barradas MC, et al. Postacute COVID-19: an Overview and Approach to Classification. Open Forum Infect Dis. 2020;7(12):ofaa509. doi:10.1093/ofid/ofaa509</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa509</ArticleId><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray T. Unpacking &#x201c;long COVID&#x201d;. CMAJ. 2021;193(9):E318&#x2013;E319. doi:10.1503/cmaj.1095923</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.1095923</ArticleId><ArticleId IdType="pmc">PMC8034303</ArticleId><ArticleId IdType="pubmed">33649174</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;1032. doi:10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Lee CH, Chow WS, et al. Long COVID in Patients With Mild to Moderate Disease: do Thyroid Function and Autoimmunity Play a Role?. Endocr Pract. 2021;27(9):894&#x2013;902. DOI:10.1016/j.eprac.2021.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2021.06.016</ArticleId><ArticleId IdType="pmc">PMC8257401</ArticleId><ArticleId IdType="pubmed">34237471</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G, Fragkou PC, Karofylakis E, et al. Hypothyroidism is associated with prolonged COVID-19-induced anosmia: a case-control study. J Neurol Neurosurg Psychiatry. 2021:jnnp-2021-326587. doi:10.1136/jnnp-2021-326587</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-326587</ArticleId><ArticleId IdType="pubmed">33879534</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jongh F, Jobsis A, Elte J. Thyroid morphology in lethal non-thyroidal illness: a post-mortem study. Eur J Endocrinol. 2001;144(3):221&#x2013;226. doi:10.1530/eje.0.1440221</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/eje.0.1440221</ArticleId><ArticleId IdType="pubmed">11248740</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei L, Sun S, Xu C, et al. Pathology of the thyroid in severe acute respiratory syndrome. Hum Pathol. 2007;38(1):95&#x2013;102. doi:10.1016/j.humpath.2006.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2006.06.011</ArticleId><ArticleId IdType="pmc">PMC7112059</ArticleId><ArticleId IdType="pubmed">16996569</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf). 2005;63(2):197&#x2013;202. doi:10.1111/j.1365-2265.2005.02325.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType="pmc">PMC7188349</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrousos GP, Kaltsas G. Post-SARS sickness syndrome manifestations and endocrinopathy: how, why, and so what? Clin Endocrinol (Oxf). 2005;63(4):363&#x2013;365. doi:10.1111/j.1365-2265.2005.02361.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02361.x</ArticleId><ArticleId IdType="pmc">PMC7162060</ArticleId><ArticleId IdType="pubmed">16181227</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilera G. The Hypothalamic&#x2013;Pituitary&#x2013;Adrenal Axis and Neuroendocrine Responses to Stress, Handbook of Neuroendocrinology. Academic Press; 2012:175&#x2013;196. doi:10.1016/B978-0-12-375097-6.10008-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-375097-6.10008-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Ye YX, Yao H. Evaluation and observation of serum thyroid hormone and parathyroid hormone in patients with severe acute respiratory syndrome. J Chi Antitub Asso. 2003;25:232&#x2013;234.</Citation></Reference><Reference><Citation>Wei L, Sun S, Zhang J, et al. Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS). Biochem Cell Biol. 2010;88(4):723&#x2013;730. doi:10.1139/O10-022</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/O10-022</ArticleId><ArticleId IdType="pubmed">20651845</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015;3(10):816&#x2013;825. doi:10.1016/S2213-8587(15)00225-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(15)00225-9</ArticleId><ArticleId IdType="pmc">PMC4979220</ArticleId><ArticleId IdType="pubmed">26071885</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 2014;24(10):1456&#x2013;1465. doi:10.1089/thy.2014.0201</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2014.0201</ArticleId><ArticleId IdType="pmc">PMC4195234</ArticleId><ArticleId IdType="pubmed">24845024</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou R, Wu C, Zhang S, et al. Euthyroid Sick Syndrome in Patients With COVID-19. Front Endocrinol (Lausanne). 2020;11:566439. doi:10.3389/fendo.2020.566439</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.566439</ArticleId><ArticleId IdType="pmc">PMC7575767</ArticleId><ArticleId IdType="pubmed">33117282</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartalena L, Bogazzi F, Brogioni S, Grasso L, Martino E. Role of cytokines in the pathogenesis of the euthyroid sick syndrome. Eur J Endocrinol. 1998;138(6):603&#x2013;614. doi:10.1530/eje.0.1380603</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/eje.0.1380603</ArticleId><ArticleId IdType="pubmed">9678522</ArticleId></ArticleIdList></Reference><Reference><Citation>Wajner SM, Maia AL. New Insights toward the Acute Non-Thyroidal Illness Syndrome. Front Endocrinol (Lausanne). 2012;3:8. doi:10.3389/fendo.2012.00008</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2012.00008</ArticleId><ArticleId IdType="pmc">PMC3356062</ArticleId><ArticleId IdType="pubmed">22654851</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Zhou W, Xu W. Thyroid Function Analysis in 50 Patients with COVID-19: a Retrospective Study. Thyroid. 2021;31(1):8&#x2013;11. doi:10.1089/thy.2020.0363</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2020.0363</ArticleId><ArticleId IdType="pubmed">32600165</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller I, Cannavaro D, Dazzi D, et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020;8(9):739&#x2013;741. doi:10.1016/S2213-8587(20)30266-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30266-7</ArticleId><ArticleId IdType="pmc">PMC7392564</ArticleId><ArticleId IdType="pubmed">32738929</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W, Guo W, Guo Y, et al. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J Endocrinol Invest. 2021;44(5):1031&#x2013;1040. doi:10.1007/s40618-020-01460-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01460-w</ArticleId><ArticleId IdType="pmc">PMC7605732</ArticleId><ArticleId IdType="pubmed">33140379</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Lin F, Tu W, et al. Thyroid dysfunction may be associated with poor outcomes in patients with COVID-19. Mol Cell Endocrinol. 2021;521:111097. doi:10.1016/j.mce.2020.111097</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2020.111097</ArticleId><ArticleId IdType="pmc">PMC7709789</ArticleId><ArticleId IdType="pubmed">33278491</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoo B, Tan T, Clarke SA, et al. Thyroid function before, during and after COVID-19. J Clin Endocrinol Metab. 2021;106(2):e803&#x2013;e811. doi:10.1210/clinem/dgaa830</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa830</ArticleId><ArticleId IdType="pmc">PMC7823247</ArticleId><ArticleId IdType="pubmed">33180932</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gerwen M, Alsen M, Little C, et al. Outcomes of Patients With Hypothyroidism and COVID-19: a Retrospective Cohort Study. Front Endocrinol (Lausanne). 2020;11:565. doi:10.3389/fendo.2020.00565</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.00565</ArticleId><ArticleId IdType="pmc">PMC7461836</ArticleId><ArticleId IdType="pubmed">33013686</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect. 2020;53(3):368&#x2013;370. doi:10.1016/j.jmii.2020.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.03.005</ArticleId><ArticleId IdType="pmc">PMC7156211</ArticleId><ArticleId IdType="pubmed">32205092</ArticleId></ArticleIdList></Reference><Reference><Citation>Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020;183(4):381&#x2013;387. doi:10.1530/EJE-20-0335</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0335</ArticleId><ArticleId IdType="pmc">PMC9494315</ArticleId><ArticleId IdType="pubmed">32698147</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee LY, Hajanto S, Rosario BH. COVID-19 complicated by Hashimoto&#x2019;s thyroiditis. Singapore Med J. 2020. doi:10.11622/smedj.2020106</Citation><ArticleIdList><ArticleId IdType="doi">10.11622/smedj.2020106</ArticleId><ArticleId IdType="pmc">PMC8801861</ArticleId><ArticleId IdType="pubmed">32668831</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabassom A, Edens MA. De Quervain Thyroiditis. StatPearls; 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">30252322</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzahrani AS, Ceresini G, Aldasouqi SA. Role of ultrasonography in the differential diagnosis of thyrotoxicosis: a noninvasive, cost-effective, and widely available but underutilized diagnostic tool. Endocr Pract. 2012;18(4):567&#x2013;578. doi:10.4158/EP11170.RA</Citation><ArticleIdList><ArticleId IdType="doi">10.4158/EP11170.RA</ArticleId><ArticleId IdType="pubmed">22440986</ArticleId></ArticleIdList></Reference><Reference><Citation>Ippolito S, Dentali F, Tanda ML. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest. 2020;43(8):1171&#x2013;1172. doi:10.1007/s40618-020-01312-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01312-7</ArticleId><ArticleId IdType="pmc">PMC7266411</ArticleId><ArticleId IdType="pubmed">32488726</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra P, Kumar KM, Kallur KG, Vadyanathan V, Nadig M, Shankar M. Demographic data of thyroiditis from a south Indian city. Indian J Endocrinol Metab. 2015;19(2):300&#x2013;302. doi:10.4103/2230-8210.149326</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2230-8210.149326</ArticleId><ArticleId IdType="pmc">PMC4319275</ArticleId><ArticleId IdType="pubmed">25729697</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney LB, Stewart C, Gaitonde DY. Thyroiditis: an integrated approach. Am Fam Phys. 2014;90:389&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">25251231</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancatella A, Ricci D, Viola N, Sgr&#xf2; D, Santini F, Latrofa F. Subacute Thyroiditis After Sars-COV-2 Infection. J Clin Endocrinol Metab. 2020;105(7):dgaa276. doi:10.1210/clinem/dgaa276</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa276</ArticleId><ArticleId IdType="pmc">PMC7314004</ArticleId><ArticleId IdType="pubmed">32436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Asfuroglu Kalkan E, Ates I. A case of subacute thyroiditis associated with Covid-19 infection. J Endocrinol Invest. 2020;43(8):1173&#x2013;1174. doi:10.1007/s40618-020-01316-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01316-3</ArticleId><ArticleId IdType="pmc">PMC7273820</ArticleId><ArticleId IdType="pubmed">32504458</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancatella A, Ricci D, Cappellani D, et al. Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series. J Clin Endocrinol Metab. 2020;105(10):dgaa537. doi:10.1210/clinem/dgaa537</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa537</ArticleId><ArticleId IdType="pmc">PMC7454668</ArticleId><ArticleId IdType="pubmed">32780854</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri RM, Campenn&#xec; A, Siracusa M, Frazzetto G, Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones. 2021;20(1):219&#x2013;221. doi:10.1007/s42000-020-00230-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42000-020-00230-w</ArticleId><ArticleId IdType="pmc">PMC7365600</ArticleId><ArticleId IdType="pubmed">32676935</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattar SAM, Koh SJQ, Rama Chandran S, Cherng BPZ. Subacute thyroiditis associated with COVID-19. BMJ Case Rep. 2020;13(8):e237336. doi:10.1136/bcr-2020-237336</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-237336</ArticleId><ArticleId IdType="pmc">PMC7449350</ArticleId><ArticleId IdType="pubmed">32843467</ArticleId></ArticleIdList></Reference><Reference><Citation>Guven M. Subacute Thyroiditis in the Course of Coronavirus Disease 2019: a Case Report. J Endocrinol Metab. 2020;10:110&#x2013;112. doi:10.14740/jem678</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/jem678</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Barrera E, Alvarez-Cisneros T, Davalos-Fuentes M. Subacute Thyroiditis Associated with COVID-19. Case Rep Endocrinol. 2020;2020:8891539. doi:10.1155/2020/8891539</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/8891539</ArticleId><ArticleId IdType="pmc">PMC7522602</ArticleId><ArticleId IdType="pubmed">33005461</ArticleId></ArticleIdList></Reference><Reference><Citation>San Juan MDJ, Florencio MQV, Joven MH. SUBACUTE THYROIDITIS IN A PATIENT WITH CORONAVIRUS DISEASE 2019. AACE Clin Case Rep. 2020;6(6):e361&#x2013;e364. doi:10.4158/ACCR-2020-0524</Citation><ArticleIdList><ArticleId IdType="doi">10.4158/ACCR-2020-0524</ArticleId><ArticleId IdType="pmc">PMC7685420</ArticleId><ArticleId IdType="pubmed">33244504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruano R, Zorzano-Martinez M, Campos A, Rius F, Hern&#xe1;ndez M. Subacute thyroiditis might be a complication triggered by SARS-CoV-2. Endocrinol Diabetes Nutr. 2020. doi:10.1016/j.endinu.2020.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.endinu.2020.09.002</ArticleId><ArticleId IdType="pmc">PMC7553120</ArticleId><ArticleId IdType="pubmed">33139217</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong WH, Shkolnik B, Saha B, Beegle S. Subacute Thyroiditis in the Setting of Coronavirus Disease 2019. Am J Med Sci. 2021;361(3):400&#x2013;402. doi:10.1016/j.amjms.2020.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2020.09.011</ArticleId><ArticleId IdType="pmc">PMC7493794</ArticleId><ArticleId IdType="pubmed">33097194</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty U, Ghosh S, Chandra A, Ray AK. Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity. BMJ Case Rep. 2020;13(12):e239953. doi:10.1136/bcr-2020-239953</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-239953</ArticleId><ArticleId IdType="pmc">PMC10577769</ArticleId><ArticleId IdType="pubmed">33370933</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehmood MA, Bapna M, Arshad M. A Case of Post-COVID-19 Subacute Thyroiditis. Cureus. 2020;12(12):e12301. doi:10.7759/cureus.12301</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.12301</ArticleId><ArticleId IdType="pmc">PMC7832738</ArticleId><ArticleId IdType="pubmed">33510992</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatri A, Charlap E, Kim A. Subacute Thyroiditis from COVID-19 Infection: a Case Report and Review of Literature. Eur Thyroid J. 2021;9(6):324&#x2013;328. doi:10.1159/000511872</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000511872</ArticleId><ArticleId IdType="pmc">PMC7705942</ArticleId><ArticleId IdType="pubmed">33708634</ArticleId></ArticleIdList></Reference><Reference><Citation>Davoodi L, Oladi Z, Jafarpour H, Zakariaei Z, Soleymani E, Razavi A. A 33-year-old man with COVID-19 presented with subacute thyroiditis: a rare case report and literature review. New Microbes New Infect. 2021;41:100871. doi:10.1016/j.nmni.2021.100871</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2021.100871</ArticleId><ArticleId IdType="pmc">PMC7982644</ArticleId><ArticleId IdType="pubmed">33777402</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohrabpour S, Heidari F, Karimi E, Ansari R, Tajdini A, Heidari F. Subacute Thyroiditis in COVID-19 Patients. Eur Thyroid J. 2021;9(6):321&#x2013;323. doi:10.1159/000511707</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000511707</ArticleId><ArticleId IdType="pmc">PMC7705932</ArticleId><ArticleId IdType="pubmed">33708633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh R, Dubey S, Sarkar A, et al. Antithyroid arthritis syndrome in a case of post-COVID-19 subacute thyroiditis. Diabetes Metab Syndr. 2021;15(3):683&#x2013;686. doi:10.1016/j.dsx.2021.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.03.015</ArticleId><ArticleId IdType="pmc">PMC7992301</ArticleId><ArticleId IdType="pubmed">33813242</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathews SE, Castellanos-Diaz J, Srihari A, et al. Subacute Thyroiditis and Heart Failure in a Patient Presenting With COVID-19. J Investig Med High Impact Case Rep. 2021;9:23247096211009412. doi:10.1177/23247096211009412</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23247096211009412</ArticleId><ArticleId IdType="pmc">PMC8056563</ArticleId><ArticleId IdType="pubmed">33853424</ArticleId></ArticleIdList></Reference><Reference><Citation>Abreu R, Miguel R, Saieg M. Subacute (De Quervain) thyroiditis during the COVID-19 pandemic. Cancer Cytopathol. 2021. doi:10.1002/cncy.22449</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncy.22449</ArticleId><ArticleId IdType="pmc">PMC8239629</ArticleId><ArticleId IdType="pubmed">33970557</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyed Resuli A, Bezgal M. Subacute Thyroiditis in COVID-19 Patients. Ear Nose Throat J. 2021;1455613211012114. doi:10.1177/01455613211012114</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01455613211012114</ArticleId><ArticleId IdType="pubmed">33974811</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Higuera L&#xf3;pez-fr&#xed;as M, Perdomo CM, Galofr&#xe9; JC. Subacute thyroiditis following COVID-19 infection. Rev Clin Esp. 2021;221(6):370&#x2013;372. doi:10.1016/j.rceng.2021.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rceng.2021.01.002</ArticleId><ArticleId IdType="pmc">PMC7997620</ArticleId><ArticleId IdType="pubmed">34059237</ArticleId></ArticleIdList></Reference><Reference><Citation>Tj&#xf8;nnfjord E, Moe RB, Ghanima W, Aballi S. Subacute thyroiditis after COVID-19. Tidsskr nor Laegeforen. 2021;141(10). doi:10.4045/tidsskr.21.0169</Citation><ArticleIdList><ArticleId IdType="doi">10.4045/tidsskr.21.0169</ArticleId><ArticleId IdType="pubmed">34182720</ArticleId></ArticleIdList></Reference><Reference><Citation>Feghali K, Atallah J, Norman C. Manifestations of thyroid disease post COVID-19 illness: report of Hashimoto thyroiditis, Graves&#x2019; disease, and subacute thyroiditis. J Clin Transl Endocrinol Case Rep. 2021;22:100094. doi:10.1016/j.jecr.2021.100094</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jecr.2021.100094</ArticleId><ArticleId IdType="pmc">PMC8387132</ArticleId><ArticleId IdType="pubmed">34462717</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato D, Nishiguchi S, Tanaka E. Successful Management of Subacute Thyroiditis Following SARS-CoV-2 Infection: a Case Report. Intern Med. 2021. doi:10.2169/internalmedicine.7913-21</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.7913-21</ArticleId><ArticleId IdType="pmc">PMC8666218</ArticleId><ArticleId IdType="pubmed">34511569</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves&#x2019; disease after COVID-19. J Endocrinol Invest. 2020;43(10):1527&#x2013;1528. doi:10.1007/s40618-020-01366-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01366-7</ArticleId><ArticleId IdType="pmc">PMC7368923</ArticleId><ArticleId IdType="pubmed">32686042</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz GP, Senger N, Carneiro-Ramos MS, Santos RA, Barreto-Chaves ML. Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy. Ther Adv Cardiovasc Dis. 2016;10(4):192&#x2013;202. doi:10.1177/1753944715623228</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753944715623228</ArticleId><ArticleId IdType="pmc">PMC5942623</ArticleId><ArticleId IdType="pubmed">26715125</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez-Blanco S, Pla-Peris B, Marazuela M. COVID-19: a cause of recurrent Graves&#x2019; hyperthyroidism? J Endocrinol Invest. 2021;44(2):387&#x2013;388. doi:10.1007/s40618-020-01440-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01440-0</ArticleId><ArticleId IdType="pmc">PMC7538276</ArticleId><ArticleId IdType="pubmed">33025554</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris A, Al Mushref M. Graves&#x2019; Thyrotoxicosis Following SARS-CoV-2 Infection. AACE Clin Case Rep. 2021;7(1):14&#x2013;16. doi:10.1016/j.aace.2020.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aace.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC7834282</ArticleId><ArticleId IdType="pubmed">33521256</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanzolla G, Marcocci C, Marin&#xf2; M. Graves&#x2019; disease and Graves&#x2019; orbitopathy following COVID-19. J Endocrinol Invest. 2021;1&#x2013;2. doi:10.1007/s40618-021-01576-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01576-7</ArticleId><ArticleId IdType="pmc">PMC8106371</ArticleId><ArticleId IdType="pubmed">33964007</ArticleId></ArticleIdList></Reference><Reference><Citation>Allam MM, El-Zawawy HT, Ahmed SM, Aly Abdelhamid M. Thyroid disease and covid-19 infection: case series. Clin Case Rep. 2021;9(6):e04225. doi:10.1002/ccr3.4225</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.4225</ArticleId><ArticleId IdType="pmc">PMC8212015</ArticleId><ArticleId IdType="pubmed">34178336</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi NK, Bansal SK. Autoimmune Thyroid Disease and Psoriasis Vulgaris after COVID-19 in a Male Teenager. Case Rep Pediatr. 2021;2021:7584729. doi:10.1155/2021/7584729</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/7584729</ArticleId><ArticleId IdType="pmc">PMC8331315</ArticleId><ArticleId IdType="pubmed">34354847</ArticleId></ArticleIdList></Reference><Reference><Citation>Montebello A. Recurrent Graves&#x2019; disease post SARS-CoV-2 infection. BMJ Case Rep. 2021;14(8):e244714. doi:10.1136/bcr-2021-244714</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-244714</ArticleId><ArticleId IdType="pmc">PMC8351485</ArticleId><ArticleId IdType="pubmed">34362755</ArticleId></ArticleIdList></Reference><Reference><Citation>Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol. 2004;150(5):605&#x2013;618. doi:10.1530/eje.0.1500605</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/eje.0.1500605</ArticleId><ArticleId IdType="pubmed">15132715</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvi M, Girasole G, Pedrazzoni M, et al. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves&#x2019; disease. J Clin Endocrinol Metab. 1996;81(8):2976&#x2013;2979. doi:10.1210/jcem.81.8.8768861</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.81.8.8768861</ArticleId><ArticleId IdType="pubmed">8768861</ArticleId></ArticleIdList></Reference><Reference><Citation>Murugan AK, Alzahrani AS. SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves&#x2019; disease. Endocrine. 2021;73(2):243&#x2013;254. doi:10.1007/s12020-021-02770-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02770-6</ArticleId><ArticleId IdType="pmc">PMC8188762</ArticleId><ArticleId IdType="pubmed">34106438</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastor S, Molina &#xc1; Sr, De Celis E. Thyrotoxic Crisis and COVID-19 Infection: an Extraordinary Case and Literature Review. Cureus. 2020;12(11):e11305. doi:10.7759/cureus.11305</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.11305</ArticleId><ArticleId IdType="pmc">PMC7714732</ArticleId><ArticleId IdType="pubmed">33282582</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartalena L, Chiovato L, Marcocci C, Vitti P, Piantanida E, Tanda ML. Management of Graves&#x2019; hyperthyroidism and orbitopathy in time of COVID-19 pandemic. J Endocrinol Invest. 2020;43(8):1149&#x2013;1151. doi:10.1007/s40618-020-01293-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01293-7</ArticleId><ArticleId IdType="pmc">PMC7241069</ArticleId><ArticleId IdType="pubmed">32441005</ArticleId></ArticleIdList></Reference><Reference><Citation>Knack RS, Hanada T, Knack RS, Mayr K. Hashimoto&#x2019;s thyroiditis following SARS-CoV-2 infection. BMJ Case Rep. 2021;14(8):e244909. doi:10.1136/bcr-2021-244909</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-244909</ArticleId><ArticleId IdType="pmc">PMC8354276</ArticleId><ArticleId IdType="pubmed">34373245</ArticleId></ArticleIdList></Reference><Reference><Citation>Varol AC, Hatice U, Gorgun S. COVID-19 and Hashimoto&#x2019;s Disease. Rev Assoc Med Bras. 2021;67(5):640. doi:10.1590/1806-9282.20210242</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1806-9282.20210242</ArticleId><ArticleId IdType="pubmed">34550248</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. 2020;382(17):e38. doi:10.1056/NEJMc2007575</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2007575</ArticleId><ArticleId IdType="pmc">PMC7161262</ArticleId><ArticleId IdType="pubmed">32268022</ArticleId></ArticleIdList></Reference><Reference><Citation>Zulfiqar AA, Lorenzo-Villalba N, Hassler P, Andr&#xe8;s E. Immune thrombocytopenic purpura in a patient with COVID-19. N Engl J Med. 2020;382(18):e43. doi:10.1056/NEJMc2010472</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2010472</ArticleId><ArticleId IdType="pmc">PMC7179995</ArticleId><ArticleId IdType="pubmed">32294340</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarian G, Quinquenel A, Bellal M, et al. Autoimmune haemolytic anaemia associated with COVID-19 infection. Br J Haematol. 2020;190(1):29&#x2013;31. doi:10.1111/bjh.16794</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16794</ArticleId><ArticleId IdType="pmc">PMC7267601</ArticleId><ArticleId IdType="pubmed">32374906</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barr&#xe9; Syndrome associated with SARSCoV-2. N Engl J Med. 2020;382(26):2574&#x2013;2576. doi:10.1056/NEJMc2009191</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009191</ArticleId><ArticleId IdType="pmc">PMC7182017</ArticleId><ArticleId IdType="pubmed">32302082</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033&#x2013;1034. doi:10.1016/S0140-6736(20)30628-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchant D, Dou Y, Luo H, et al. Bosentan enhances viral load via endothelin-1 receptor type-A-mediated p38 mitogen-activated protein kinase activation while improving cardiac function during coxsackievirus-induced myocarditis. Circ Res. 2009;104(6):813&#x2013;821. doi:10.1161/CIRCRESAHA.108.191171</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.108.191171</ArticleId><ArticleId IdType="pubmed">19213955</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantos C, Mourouzis I. Translating thyroid hormone effects into clinical practice: the relevance of thyroid hormone receptor &#x3b1;1 in cardiac repair. Heart Fail Rev. 2015;20(3):273&#x2013;282. doi:10.1007/s10741-014-9465-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-014-9465-4</ArticleId><ArticleId IdType="pubmed">25501869</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato R, Ariyoshi N, Hasegawa D, et al. Effects of inotropes on the mortality in patients with septic shock. J Intensive Care Med. 2021;36(2):211&#x2013;219. doi:10.1177/0885066619892218</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066619892218</ArticleId><ArticleId IdType="pubmed">31793373</ArticleId></ArticleIdList></Reference><Reference><Citation>Padhi R, Kabi S, Panda BN, Jagati S. Prognostic significance of nonthyroidal illness syndrome in critically ill adult patients with sepsis. Int J Crit Illn Inj Sci. 2018;8(3):165&#x2013;172. doi:10.4103/IJCIIS.IJCIIS_29_17</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/IJCIIS.IJCIIS_29_17</ArticleId><ArticleId IdType="pmc">PMC6116306</ArticleId><ArticleId IdType="pubmed">30181975</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan V, Gorecki M, Costello C, Schultz E, Zhang Y, Gerdes AM. Cardioprotection by triiodothyronine following caloric restriction via long noncoding RNAs. Biomed Pharmacother. 2020;131:110657. doi:10.1016/j.biopha.2020.110657</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110657</ArticleId><ArticleId IdType="pubmed">32942153</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantos C, Tseti I, Mourouzis I. Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial. Crit Care. 2020;24(1):209. doi:10.1186/s13054-020-02934-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02934-2</ArticleId><ArticleId IdType="pmc">PMC7209969</ArticleId><ArticleId IdType="pubmed">32384906</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantos C, Kostopanagiotou G, Armaganidis A, Trikas A, Tseti I, Mourouzis I. Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):573. doi:10.1186/s13063-020-04474-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-020-04474-0</ArticleId><ArticleId IdType="pmc">PMC7316579</ArticleId><ArticleId IdType="pubmed">32586399</ArticleId></ArticleIdList></Reference><Reference><Citation>Varedi M, Moattari A, Amirghofran Z, Karamizadeh Z, Feizi H. Effects of hypo- and hyperthyroid states on herpes simplex virus infectivity in the rat. Endocr Res. 2014;39(2):50&#x2013;55. doi:10.3109/07435800.2013.808208</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07435800.2013.808208</ArticleId><ArticleId IdType="pubmed">23883178</ArticleId></ArticleIdList></Reference><Reference><Citation>Salako O, Okunade K, Allsop M, et al. Upheaval in cancer care during the COVID-19 outbreak. Ecancermedicalscience. 2020;14:ed97. doi:10.3332/ecancer.2020.ed97</Citation><ArticleIdList><ArticleId IdType="doi">10.3332/ecancer.2020.ed97</ArticleId><ArticleId IdType="pmc">PMC7134578</ArticleId><ArticleId IdType="pubmed">32269597</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen AY, Shindo M. Ethical framework for head and neck endocrine surgery in the COVID-19 pandemic. Head Neck. 2020;42(7):1418&#x2013;1419. doi:10.1002/hed.26240</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.26240</ArticleId><ArticleId IdType="pmc">PMC7272909</ArticleId><ArticleId IdType="pubmed">32400943</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzahrani AS, Al Mourad M, Hafez K, et al. Diagnosis and Management of Hypothyroidism in Gulf Cooperation Council (GCC) Countries. Adv Ther. 2020;37(7):3097&#x2013;3111. doi:10.1007/s12325-020-01382-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-020-01382-2</ArticleId><ArticleId IdType="pmc">PMC7467410</ArticleId><ArticleId IdType="pubmed">32488658</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatraju PK, Wurfel MM, Himmelfarb J. Trajectory of Kidney Function: the Canary in Sepsis. Am J Respir Crit Care Med. 2020;202(9):1211&#x2013;1212. doi:10.1164/rccm.202007-2627ED</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202007-2627ED</ArticleId><ArticleId IdType="pmc">PMC7605179</ArticleId><ArticleId IdType="pubmed">32716638</ArticleId></ArticleIdList></Reference><Reference><Citation>Dworakowska D, Grossman AB. Thyroid disease in the time of COVID-19. Endocrine. 2020;68(3):471&#x2013;474. doi:10.1007/s12020-020-02364-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02364-8</ArticleId><ArticleId IdType="pmc">PMC7275975</ArticleId><ArticleId IdType="pubmed">32507963</ArticleId></ArticleIdList></Reference><Reference><Citation>Prete A, Falcone M, Bottici V, et al. Thyroid cancer and COVID-19: experience at one single thyroid disease referral center. Endocrine. 2021;72(2):332&#x2013;339. doi:10.1007/s12020-021-02650-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02650-z</ArticleId><ArticleId IdType="pmc">PMC7912964</ArticleId><ArticleId IdType="pubmed">33638758</ArticleId></ArticleIdList></Reference><Reference><Citation>Katopodis P, Kerslake R, Davies J, et al. COVID-19 and SARS-CoV-2 host cell entry mediators: expression profiling of TMRSS4 in health and disease. Int J Mol Med. 2021;47(4):64. doi:10.3892/ijmm.2021.4897</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2021.4897</ArticleId><ArticleId IdType="pmc">PMC7914073</ArticleId><ArticleId IdType="pubmed">33649798</ArticleId></ArticleIdList></Reference><Reference><Citation>Smulever A, Abelleira E, Bueno F, Pitoia F. Thyroid cancer in the Era of COVID-19. Endocrine. 2020;70(1):1&#x2013;5. doi:10.1007/s12020-020-02439-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02439-6</ArticleId><ArticleId IdType="pmc">PMC7402074</ArticleId><ArticleId IdType="pubmed">32754886</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghavan D, Tan AR, Story ES, et al. Management changes for patients with endocrine-related cancers in the COVID-19 pandemic. Endocr Relat Cancer. 2020;27(9):R357&#x2013;R374. doi:10.1530/ERC-20-0229</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/ERC-20-0229</ArticleId><ArticleId IdType="pubmed">32744242</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrachimis A, Iakovou I, Giannoula E, Giovanella L. ENDOCRINOLOGY IN THE TIME OF COVID-19: management of thyroid nodules and cancer. Eur J Endocrinol. 2020;183(1):G41&#x2013;G48. doi:10.1530/EJE-20-0269</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0269</ArticleId><ArticleId IdType="pmc">PMC7938009</ArticleId><ArticleId IdType="pubmed">32438345</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey RT, Valk GD, Schalin-J&#xe4;ntti C, Grossman AB, Thakker RV. ENDOCRINOLOGY IN THE TIME OF COVID-19: clinical management of neuroendocrine neoplasms (NENs). Eur J Endocrinol. 2020;183(2):G79&#x2013;G88. doi:10.1530/EJE-20-0424</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0424</ArticleId><ArticleId IdType="pmc">PMC7938008</ArticleId><ArticleId IdType="pubmed">32554825</ArticleId></ArticleIdList></Reference><Reference><Citation>Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2020;1&#x2013;13. doi:10.1007/s11154-020-09615-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-020-09615-z</ArticleId><ArticleId IdType="pmc">PMC7688298</ArticleId><ArticleId IdType="pubmed">33241508</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta V, Goel S, Kabarriti R, et al. Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System. Cancer Discov. 2020;10(7):935&#x2013;941. doi:10.1158/2159-8290.CD-20-0516</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-20-0516</ArticleId><ArticleId IdType="pmc">PMC7334098</ArticleId><ArticleId IdType="pubmed">32357994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kathuria-Prakash N, Mosaferi T, Xie M, et al. COVID-19 Outcomes of Patients With Differentiated Thyroid Cancer: a Multicenter Los Angeles Cohort Study. Endocr Pract. 2021;27(2):90&#x2013;94. doi:10.1016/j.eprac.2020.12.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2020.12.013</ArticleId><ArticleId IdType="pmc">PMC7831810</ArticleId><ArticleId IdType="pubmed">33551317</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai M, Liu D, Liu M, et al. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: a Multicenter Study during the COVID-19 Outbreak. Cancer Discov. 2020;10(6):783&#x2013;791. doi:10.1158/2159-8290.CD-20-0422</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-20-0422</ArticleId><ArticleId IdType="pmc">PMC7309152</ArticleId><ArticleId IdType="pubmed">32345594</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone R, Grani G, Ramundo V, et al. Cancer Care During COVID-19 Era: the Quality of Life of Patients With Thyroid Malignancies. Front Oncol. 2020;10:1128. doi:10.3389/fonc.2020.01128</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.01128</ArticleId><ArticleId IdType="pmc">PMC7344223</ArticleId><ArticleId IdType="pubmed">32714873</ArticleId></ArticleIdList></Reference><Reference><Citation>Klain M, Nappi C, Maurea S, et al. Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challenge. Eur J Nucl Med Mol Imaging. 2021;48(3):831&#x2013;836. doi:10.1007/s00259-020-05041-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05041-0</ArticleId><ArticleId IdType="pmc">PMC7509822</ArticleId><ArticleId IdType="pubmed">32965559</ArticleId></ArticleIdList></Reference><Reference><Citation>Medas F, Ansaldo GL, Avenia N, et al.; Italian Society of Endocrine Surgery (SIUEC) Collaborative Group. Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study. Br J Surg. 2021;108(4):e166&#x2013;e167. doi:10.1093/bjs/znab012</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjs/znab012</ArticleId><ArticleId IdType="pmc">PMC7989577</ArticleId><ArticleId IdType="pubmed">33659983</ArticleId></ArticleIdList></Reference><Reference><Citation>Givi B, Schiff BA, Chinn SB, et al. Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic. JAMA Otolaryngol Head Neck Surg. 2020;146(6):579&#x2013;584. doi:10.1001/jamaoto.2020.0780</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2020.0780</ArticleId><ArticleId IdType="pubmed">32232423</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J, Rizvi H, Egger JV, Preeshagul IR, Wolchok JD, Hellmann MD. Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers. Cancer Discov. 2020;10(8):1121&#x2013;1128. doi:10.1158/2159-8290.CD-20-0596</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-20-0596</ArticleId><ArticleId IdType="pmc">PMC7416461</ArticleId><ArticleId IdType="pubmed">32398243</ArticleId></ArticleIdList></Reference><Reference><Citation>Palladino R, Migliatico I, Sgariglia R, et al. Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic. Endocrine. 2021;71(1):20&#x2013;25. doi:10.1007/s12020-020-02559-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02559-z</ArticleId><ArticleId IdType="pmc">PMC7719849</ArticleId><ArticleId IdType="pubmed">33284396</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>